Inaccuracies in MTS assays: Major distorting effects of medium, serum albumin, and fatty acids

BioTechniques

Volumn 37, Issue 3, 2004, Pages 406-412

  Huang, Kuang Tzu ^a   Chen, Yen Hao ^a   Walker, Ameae M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORPTION; CELL CULTURE; CONCENTRATION (PROCESS); FATTY ACIDS; PROTEINS;

CELL NUMBER; SERUM ALBUMIN; SOLUBLE FORMAZAN ASSAYS;

ASSAYS;

3 (4,5 DIMETHYLTHIAZOL 2 YL) 5 (3 CARBOXYMETHOXYPHENYL) 2 (4 SULFOPHENYL) 2H TETRAZOLIUM; EPIDERMAL GROWTH FACTOR; FATTY ACID; GLUCOSE; INSULIN; SERUM ALBUMIN; TETRAZOLIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CELL CULTURE; CELL FREE SYSTEM; CELL GROWTH; CULTURE MEDIUM; IN VITRO STUDY; METHODOLOGY; MOUSE; NONHUMAN;

ANIMALIA;

EID: 4444240302     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/04373st05     Document Type: Article

References (19)

1. Cory, A.H., T.C. Owen, J.A. Barltrop, and J.G. Cory. 1991. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 3:207-212.
2. Satoh, T., H. Isobe, K. Ayukawa, H. Sakai, and H. Nawata. 1996. The effects of pravastatin, an HMG-CoA reductase inhibitor, on cell viability and DNA production of rat hepatocytes. Life Sci. 59:1103-1108.
3. Shearman, M.S. 1996. Cellular MTT reduction distinguishes the mechanism of action of beta-amyloid from that of tachykinin receptor peptides. Neuropeptides 30:125-132.
4. Alley, M.C., D.A. Scudiero, A. Monks, M.L. Hursey, M.J. Czerwinski, D.L. Fine, B.J. Abbott, J.G. Mayo, et al. 1988. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48:589-601.
5. Berridge, M.V. and A.S. Tan. 1993. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch. Biochem. Biophys. 303:474-482.
6. Marshall, N.J., C.J. Goodwin, and S.J. Holt. 1995. A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function. Growth Regul. 5:69-84.
7. Liu, Y., D.A. Peterson, H. Kimura, and D. Schubert. 1997. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 69:581-593.
8. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.
9. Twentyman, P.R. and M. Luscombe. 1987. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br. J. Cancer 56:279-285.
10. Goodwin, C.J., S.J. Holt, S. Downes, and N.J. Marshall. 1995. Microculture tetrazolium assays: a comparison between two new tetrazolium salts, XTT and MTS. J. Immunol. Methods 179:95-103.
11. Bernas, T. and J. Dobrucki. 1999. Reduction of a tetrazolium salt, CTC, by intact HepG2 human hepatoma cells: subcellular localisation of reducing systems. Biochim. Biophys. Acta 1451:73-81.
12. Ishiyama, M., H. Tominaga, M. Shiga, K. Sasamoto, Y. Ohkura, and K. Ueno. 1996. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol. Pharm. Bull. 19:1518-1520.
13. Scudiero, D.A., R.H. Shoemaker, K.D. Paull, A. Monks, S. Tierney, T.H. Nofziger, M.J. Currens, D. Seniff, et al. 1988. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48:4827-4833.
14. Barltrop, J.A., T.C. Owen, A.H. Cory, and J.G. Cory. 1991. 5-(3-Carboxylmethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl) tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)- 2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans as cell-viability indicators. Bioorg. Med. Chem. Lett. 1:611-614.
15. Chakrabarti, R., S. Kundu, and S. Kumar. 2000. Vitamin A as an enzyme that catalyzes the reduction of MTT to formazan by vitamin C. J. Cell Biochem. 80:133-138.
16. Hardy, S., W. El-Assaad, E. Przybytkowski, E. Joly, M. Prentki, and Y. Langelier. 2003. Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. A role for cardiolipin. J. Biol. Chem. 278:31861-31870.
17. Hardy, S., Y. Langelier, and M. Prentki. 2000. Oleate activates phosphatidylinositol 3-kinase and promotes proliferation and reduces apoptosis of MDA-MB-231 breast cancer cells, whereas palmitate has opposite effects. Cancer Res. 60:6353-6358.
18. Wickramasinghe, N.S., H. Jo, J.M. McDonald, and R.W. Hardy. 1996. Stearate inhibition of breast cancer cell proliferation. A mechanism involving epidermal growth factor receptor and G-proteins. Am. J. Pathol. 148:987-995.
19. Shin, S.H., F. Si, A. Chang, and G.M. Ross. 1997. Dopamine requires ascorbic acid to be the prolactin release-inhibiting factor. Am. J. Physiol. 273:E593-598.